-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
AAV vectors can be safely used in the body to deliver DNA into cells, and two AAV-based gene therapies are currently FDA-approved
The Phase 1 clinical trial enrolled eight HIV-infected adults who had been on stable antiretroviral therapy for at least 3 months
"This work represents the first successful AAV-based production of monoclonal antibodies of any type by anyone," said co-author Alejandro B.
The findings have broad clinical implications for the possible prevention or treatment of HIV and other infections, Balazs noted
The technique was originally developed by Balazs as a postdoc in the laboratory of Nobel laureate Dr.
Additional study authors include Joseph P.
This work was supported by internal funding from the National Institute of Allergy and Infectious Diseases through the NIH Internal Research Program
Journal Reference :
Joseph P.